BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share.
On August 12, BlackRock increased its stake in Sinopharm Tech (01801) by 139,500 shares, at a price of HKD 95.375 per share, for a total amount of approximately HKD 13,304,800.
According to the latest information from the Hong Kong Stock Exchange, on August 12, BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share, totaling approximately HKD 13.3048 million. After this increase, the latest number of shares held is approximately 87,317,900, representing a holding percentage of 5.01%.
Related Articles
HAO WEN HLDGS (08019) announced its interim results with a net profit of 15.571 million yuan, turning a profit compared to the same period last year.
CRYPTO FLOW (08198) issues a profit warning, expecting a net loss of no less than HKD 54 million in the first half of the year.
CHINAGOLDINTL (02099): The slope management plan for Changshanhao Mine has been approved, and mining operations are expected to resume.
HAO WEN HLDGS (08019) announced its interim results with a net profit of 15.571 million yuan, turning a profit compared to the same period last year.
CRYPTO FLOW (08198) issues a profit warning, expecting a net loss of no less than HKD 54 million in the first half of the year.
CHINAGOLDINTL (02099): The slope management plan for Changshanhao Mine has been approved, and mining operations are expected to resume.
RECOMMEND
